SOPH:NASDAQ, SOPHiA GENETICS SA

SOPH stock overview

SOPHiA GENETICS SA (SOPH:NASDAQ) closed at $7.35 on October 23, 2026, up 4.26% on the day. The stock trades 18.2% below its 52-week high of $8.98 and 91.9% above its 52-week low of $3.83. Over the past year, it gained 72.9%. SOPHiA GENETICS SA is part of the Health Care sector.

Key figures

Price
$7.35
Day change
+4.26%
Volume
455,213
Average volume
592,496
Market cap
625M+
52-week range
$3.83 – $8.98
50-day average
$7.90
200-day average
$5.87

Price action over the past year

In 252 trading sessions since October 23, 2025, SOPH closed higher on 124 days (49%). Its best day was August 4, 2026 (+20.21%) and its worst was March 3, 2026 (-11.26%). The stock moved 10% or more in a single session 6 times.

Recent signals

SOPH news

About SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.

Similar stocks

Find more stocks like SOPH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.